文献速递胃肠外科

微创胃癌根治术重建技术与相关并发症:GastroBenchmark与GASTRODATA数据库分析

Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases.
PubMed 文献 · Ann Surg · 2024-08-05

该研究基于2017—2021年43个中心的9356例肿瘤性胃切除术,分析微创全胃切除(miTG,n=878)与微创远端胃切除(miDG,n=3334)的吻合与重建技术对术后并发症的影响。结果显示miTG的吻合口漏、总体并发症、严重并发症及90天死亡率均高于miDG;miTG中线性吻合器(LS)的吻合口漏和严重并发症最低,多因素分析证实吻合技术是预测因素。miDG中肠道重建方式不影响并发症。

要点

  • 在肿瘤学允许时,优先选择miDG而非miTG,因miTG术后并发症显著更高。
  • miTG中LS吻合的吻合口漏(3.4%)和严重并发症(9.7%)最低,建议西方中心优先采用。
  • miDG中Billroth I、Billroth II或Roux重建对吻合口漏、总体及严重并发症和死亡率无显著影响,可按术者偏好选择。

核心结论

  • 在肿瘤学合适的情况下,应优先选择微创远端胃切除而非微创全胃切除,因其术后并发症显著更低。
  • 对于微创全胃切除,线性吻合器(LS)应作为西方中心的首选吻合技术。
  • 远端胃切除的肠道重建方式不影响并发症,可根据术者偏好选择。

研究设计与样本

  • 回顾性分析GastroBenchmark和GASTRODATA数据库中2017—2021年43个中心的9356例肿瘤性胃切除术。
  • 纳入微创全胃切除(miTG)878例和微创远端胃切除(miDG)3334例。
  • 主要终点为吻合口漏(AL)率和术后并发症,采用多因素分析。

主要发现

  • miTG相比miDG的吻合口漏(5.2% vs 1.1%)、总体并发症(28.7% vs 16.3%)、严重并发症(15.7% vs 8.2%)及90天死亡率(1.6% vs 0.5%)均更高。
  • miTG中吻合口漏率:CS 4.3%、HS 7.9%、LS 3.4%;严重并发症:LS 9.7%、CS 16.2%、HS 12.7%。
  • 多因素分析证实吻合技术是吻合口漏、总体并发症和严重并发症的预测因素。
  • miDG中吻合口漏率(BI 1.4%、BII 0.8%、RX 1.2%)、总体并发症(BI 14.5%、BII 15.0%、RX 18.7%)、严重并发症(BI 7.9%、BII 9.1%、RX 7.2%)及死亡率(BI 0%、BII 0.1%、RY 1.1%)不受肠道重建方式影响。

临床怎么用

  • 在肿瘤学允许时,优先选择微创远端胃切除以降低术后并发症。
  • 微创全胃切除时,优先采用线性吻合器(LS)吻合以降低吻合口漏和严重并发症风险。
  • 远端胃切除的肠道重建方式可根据术者偏好选择,无需因并发症风险而强制特定方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Various anastomotic and reconstruction techniques are used for minimally invasive total (miTG) and distal gastrectomy (miDG). Their effects on postoperative morbidity have not been extensively studied. METHODS: MiTG and miDG patients were selected from 9356 oncological gastrectomies performed in 2017-2021 in 43 centers. Endpoints included anastomotic leakage (AL) rate and postoperative morbidity tested by multivariable analysis. RESULTS: Three major anastomotic techniques [circular stapled (CS); linear stapled (LS); and hand sewn (HS)], and 3 major bowel reconstruction types [Roux (RX); Billroth I (BI); Billroth II (BII)] were identified in miTG (n=878) and miDG (n=3334). Postoperative complications, including AL (5.2% vs 1.1%), overall (28.7% vs 16.3%), and major morbidity (15.7% vs 8.2%), as well as 90-day mortality (1.6% vs 0.5%) were higher after miTG compared with miDG. After miTG, the AL rate was higher after CS (4.3%) and HS (7.9%) compared with LS (3.4%). Similarly, major complications (LS: 9.7%, CS: 16.2%, and HS: 12.7%) were lowest after LS. Multivariate analysis confirmed anastomotic technique as a predictive factor for AL, overall, and major complications. In miDG, AL rate (BI: 1.4%, BII 0.8%, and RX 1.2%), overall (BI: 14.5%, BII: 15.0%, and RX: 18.7%), and major morbidity (BI: 7.9%, BII: 9.1%, and RX: 7.2%), and mortality (BI: 0%, BII: 0.1%, and RY: 1.1%%) were not affected by bowel reconstruction. CONCLUSIONS: In oncologically suitable situations, miDG should be preferred to miTG, as postoperative morbidity is significantly lower. LS should be a preferred anastomotic technique for miTG in Western Centers. Conversely, bowel reconstruction in DG may be chosen according to the surgeon's preference.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Schneider MA, Kim J, Berlth F, et al. Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases. Ann Surg. 2024. PMID: 39101212. doi:10.1097/SLA.0000000000006470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。